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Abstract. We cloned a novel ankyfin, Ank3, from 
mouse kidney cDNA. The full-length transcript is pre- 
dicted to encode a 214-kD protein containing an 89 kD, 
NH2 terminal "repeat" domain; a 65 kD, central "spec- 
trin-binding" domain; and a 56 kD, COOH-terminal 
"regulatory" domain. The Ank3 gene maps to mouse 
Chromosome 10, ~36 cM from the centromere, a locus 
distinct from Ankl and Ank2. 
Ank3 is the major kidney ankyrin. Multiple tran- 
scripts of approximately 7.5, 6.9, 6.3, 5.7, 5.1, and 4.6 kb 
are highly expressed in kidney where Ankl and Ank2 
mRNAs are barely detectable. The smaller mRNAs 
(~<6.3 kb) lack the entire repeat domain. These tran- 
scripts have a unique 5'untranslated region and NH  E- 
terminal sequence and encode a predicted protein of 
121 kD. Two small sequences of 21 and 18 amino acids 
are alternatively spliced at the junction of the repeat 
and spectrin-binding domains in the larger (~>6.9 kb) 
RNAs. Alternative splicing of a 588 bp sequence (cor- 
responding to a 21.5-kD acidic amino acid sequence) 
within the regulatory domain also occurs. 
Ank3 is much more widely expressed than previously 
described ankyrins. By Northern hybridization or im- 
munocytochemistry, it is present in most epithelial 
cells, in neuronal axons, in muscle cells, and in mega- 
karyocytes/platelets, macrophages, and the interstitial 
cells of Leydig (testis). On immunoblots, an antibody 
raised to a unique region of the regulatory domain de- 
tects multiple Ank3 isoforms in the kidney (215,200, 
170, 120, 105 kD) and in other tissues. The 215/200 kD 
and 120/105-kD kidney proteins are close to the sizes 
predicted for the 7.5/6.9- and 6.3/5.7-kb RNAs (with/ 
without the 588-bp acidic insert). Interestingly, it ap- 
pears that Ank3 exhibits a polarized distribution only 
in tissues that express the ~7.0-kb isoforms, the only 
isoforms in the kidney that contain the repeat domain. 
In tissues where smaller transcripts (<~6.3 kb) are ex- 
pressed, Ank3 is diffusely distributed in some or all 
cells and may be associated with cytoplasmic structures. 
We conclude that Ank3 is a broadly distributed epi- 
thelial ankyrin and is the major ankyrin in the kidney 
and other tissues, where it plays an important role in 
the polarized distribution of many integral membrane 
proteins. 
T 
HE ankyrins are a family of conserved proteins that 
link  integral  membrane  proteins  to  the  spectrin- 
based membrane  skeleton  (reviewed in reference 
53). Ankyrins are present in a wide variety of vertebrate 
cells,  and  ankyrin-like  proteins  have  been described in 
primitive organisms such as fruit flies (Drosophila melano- 
gaster) (24) and worms (Caenorhabditis elegans) (Otsuka, 
A. J., R. Franco, B. Yang, K-H. Shim, L. Z. Tang, and A. 
Jeyaprakash. 1991. J Cell Biol. 115:465a). 
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Two vertebrate ankyrin genes have been cloned and se- 
quenced. The first, erythrocyte ankyrin (human gene sym- 
bol ANK1/mouse gene symbol Ankl) 1 is located on chro- 
mosome 8 in both humans and mice (41, 45, 46, 64, 65). 
Ankl links the J~ subunit of spectrin to the cytoplasmic do- 
main  of  the  transmembrane  anion  exchanger,  band  3 
1. Nomenclature: In this paper ankyrin genes are indicated by their as- 
signed genetic symbols: ANK1, ANK2, etc.  (human genes) and Ankl, 
Ank2, etc.  (mouse genes) (53).  The corresponding proteins  are Ankl, 
Ank2, etc. Ankl is also called erythrocyte ankyrin or ankyrinR, and Ank2 
is called brain ankyrin or ankyrin  B (12). AnkyrinG, a novel ankyrin local- 
ized to axons (37) is an isoform of Ank3. 
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critical to the stability of the RBC membrane; genetic de- 
fects in Ankl  can result in severe hemolytic anemia (44, 
46, 65). Ankl is highly expressed not only in erythroid tis- 
sues, but also in Purkinje cells and granule cells of the cer- 
ebellum, in motor neurons of the spinal column, and in a 
small subset of neurons in the hippocampus (35, 54). How- 
ever, it is the second member of the ankyrin gene family, 
brain ankyrin or Ank2, that is the major form of ankyrin in 
the nervous system  (52).  Ank2 is alternatively spliced to 
form several species, including 220- and 440-kD isoforms 
(12). In rats,  the 220-kD  isoform predominates in adults, 
while the 440-kD isoform is most highly expressed during 
the  neonatal  period  (12).  The 220-kD  isoform is broadly 
distributed in the brain, being present in neuron cell bodies 
and dendrites and in glia (12,  36).  In contrast, the 440-kD 
2. Abbreviations used in this paper: cM, centimorgans; dNTP, deoxynucle- 
otide triphosphates; GCG, Genetics Computer Group; GST, glutathione 
S  transferase; RBC,  red blood cell;  RFLP,  restriction fragment length 
polymorphism; RT-PCR,  reverse  transcription-PCR; SSLP,  simple  se- 
quence length polymorphism;  TTBS, Tris-Tween 20 buffered saline. 
isoform appears to be targeted specifically to unmyelinated 
axons  and  dendrites.  Its  expression decreases  coincident 
with myelination (12). Ank2 is encoded by a gene on hu- 
man chromosome 4q (62) and mouse Chromosome 3 (54). 
Structurally,  both Ankl  and Ank2 consist of three do- 
mains: an NH2-terminal "repeat" domain that binds band 
3 (AE1) (16), AE3 (48), tubulin (16), and other proteins; a 
central "spectrin-binding" domain that binds spectrin and 
possibly vimentin (18, 28, 55); and a COOH-terminal "reg- 
ulatory"  domain,  so-called  because  it  can  modulate  the 
binding affinities of the first two domains (19). 
The wide tissue distribution of ankyrin immunoreactive 
proteins  and  the  limited  expression  of Ankl  and  Ank2 
transcripts  suggest  that  additional  ankyrin  genes  exist. 
Here, we report the isolation, cDNA sequence, genetic lo- 
calization  and  protein/mRNA  distribution  of  a  novel 
ankyrin, Ank3, in the mouse. Ank3 is the most widely dis- 
tributed ankyrin. It is the major form of ankyrin in mouse 
kidney and other epithelial tissues, and it is also expressed 
in macrophages, megakaryocytes, and Leydig cells; in car- 
diac, smooth, and skeletal muscle; in the initial segments 
Table L Oligonucleotide  Primers 
Location 
in Ank3 
Name  Sequence  (bp, 5'--*3') 
Degenerate oligonucleotides* 
A  5 '-G===CC  A 
A 
Spel 
CTAG 
,,Q,, 
I  TGG  I  GAA  I  G._~AT  I  A_.T.TT 
G  C  C 
W  E  O  I 
B  3'-ACA 
G 
C 
C  3'-GGI 
TAC 
M 
ATA 
fi 
Y 
TGI  [  CTA 
G__ 
T  D 
TAC  [  CGI 
M  A 
CTA 
D 
ZZT 
C_ 
K 
TTT 
c 
K 
A...A_A-5' 
D  3'-A..~AA 
__G 
F 
E2a  5'-CAA 
Q 
E2b  5'-CAA 
Q 
Other oligonucleotides 
4B 
19D 
A3REGR 1 
A3REGR2 
A 3 REGF 1 
TGI  TGI 
T  T 
Kpnl 
GGT  [  AC~ 
G  T 
Kpnl 
GGT  I  AC£ 
G  T 
[  T__T.TA 
N 
I  ACI 
[  ACI 
CAI 
V 
CCI 
G 
P/A 
CCI 
G 
P/A 
AGI  [ 
S 
CTI  I 
L 
CTI  ] 
L 
3'-GGTTCTCCTAGGCACACCCAGAGGTCC-5' 
5'-CAGAAACGATGAATGAAGTCCTCGATT-3' 
3'-TATCAGTGGTTCTCACCTCACACCCAGTCGACG-5' 
3'-CAGTCAGGTCCTGGTGAACCAGTATGACGGTCA-5' 
5'-CACATAAAAAGGCTGAGAAGGCAGACAGACGCC-3' 
I  ACI  I  GGI 
T  G 
Sail 
CAG  CTG 
V  D 
[  ACI  I  A_...CC-3'  3822~3850 
T  T 
[  TTT  [  T....QG-5'  4081--+4053 
C 
K  T 
CGI 
A 
CAT 
C 
H 
C...~AT 
C 
H 
EcoRl 
GCTT  I  AAG 
"R"  F 
TGG  [  G..ff_C-3' 
W  A 
CTI  I  G...ff_C-3' 
L  A 
I  ACC-5' 
W 
4000~3984 
3911~3882 
2091~2116 
2091~2116 
3600~3574 
2515-~2541 
6053~6021 
5985~5953 
4372-*4404 
*Degenerate oligonucleotides were constructed  to match the amino acid sequences shown, with the exception that the 5' end of some oligonucleotides was modified to include a 
restriction  site. Sense oligonucleotides are shown with the 5' end on the left; antisense oligonucleotides have the 5' end on the fight. The nucleotides that  match sequences in Ank-3 
are underlined.  The locations of the matching sequences is shown at the right (numbered  from the 5' end of Ank3-7kb, Fig. 3). 
L deoxyinosine triphosphate. 
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third distinct member of the ankyrin gene family to be de- 
scribed. 
Materials and Methods 
Preparation of RNA and Northern Blots 
Total RNA was isolated by the guanidinium thiocyanate-phenol-chloro- 
form method (13).  Polyadenylated RNA (polyA(+)-RNA, also termed 
mRNA) was isolated by oligo(dT) chromatography (57).  For northern 
blots total RNA or polyA(+)-RNA was separated by denaturing gel elec- 
trophoresis, transferred to nylon filters (Zetabind; AMF Cuno, Meriden, 
CT),  and hybridized with 32p-labeled  probes using standard techniques 
(57).  Hybridizations and post-hybridization washes were performed at 
42°C and 65°C, respectively, as described (54). 
Primer Sequences and Hybridization Probes 
The primer sequences used in PCR and reverse transcription PCR (RT- 
PCR) experiments described in this study are listed in Table I. The loca- 
tions of the hybridization probes used to screen eDNA libraries, map 
Ank3 by Southern hybridization, and analyze Ank3 transcripts by north- 
ern hybridization are illustrated in Fig. 3. 
Cloning of  Ank3 by RT-PCR 
PCR1. This RT-PCR product was the initial clone of Ank3 and was ob- 
tained using degenerate oligonucleotide primers A, B, and C  (Table I). 
The cDNA synthesis reaction included (20 Ixl total volume): 1 I~g mouse 
polyA(+)-RNA (kidney, brain, thymus), 4 ~l 5x eDNA synthesis buffer 
(GIBCO BRL Life Technologies, Gaithersburg, MD), 1 mM DTT, 20 U 
RNasin (Promega Biotec, Madison, WI), 10 pmol of primer B, and 200 U 
Superscript  TM RNase H- M-MLV reverse transcriptase (GIBCO BRL). 
The mixture was incubated at 37°C  for 60 rain and the cDNA-mRNA 
complex was purified by phenol extraction and ethanol precipitation. The 
first-strand eDNA was amplified by PCR in a reaction mixture containing 
(100 ~L1 total volume): 10 ~1 10X PCR buffer (Boehringer-Mannheim Bio- 
chemicals, Indianapolis, IN), 200  IxM of each deoxynucleotide triphos- 
phate (dNTP), 100 pmol of degenerate oligonucleotide primers A and B, 5 
I~1 (25%) of the first-strand cDNA reaction, and 2.5 U Taql DNA poly- 
merase  (Boehringer-Mannheim Biochemicals). The  PCR  reaction  was 
conducted for 30 cycles (95°C,  1 min; 65°C, 1.5 min; 72°C, 1.5 min) with a 
15-min incubation at 72°C following the last cycle. The RT-PCR reaction 
yielded a 260-bp product from brain and kidney mRNA that hybridized 
with  an  internal  oligonucleotide (oligonucleotide  C)  that  was  5'  end- 
labeled with 3~-[32p]-ATP (3,000 Ci/mmol) and polynucleotide kinase (57). 
This product (PCR1) was purified from agarose using a Spin-X centrifuge 
filter (Costar Corp., Cambridge, MA), and subcloned (57) into the Blue- 
script KSII (+) vector (Stratagene, La Jolla, CA) for sequencing. 
PCR2. This RT-PCR clone bridged the junction between the repeat 
and  spectrin-binding domains. It was obtained as described above for 
PCRI. Reverse transcription was primed with primer B  and the cDNA 
was amplified using primer D  (representing a conserved sequence in the 
spectrin-binding domain)  and  a  1:1  mixture  of primers  E2a  and  E2b 
(which encode several versions of the highly conserved -G-TPLH-A se- 
quence found at the beginning of many ankyrin repeats). The product 
(1,925 bp) was cut at two internal PstI sites (bps 2,257 and 3,429) and the 
major fragment (PCR2, NI.1 kb) was subcloned into Bluescript KSII(+) 
and sequenced. 
PCR3, PCR4, and PCRS. These  products were  obtained by RT-PCR 
using a single tube assay (63) under the following reaction conditions (25 
Ixl total volume): 0.5-1.0 Ixg mRNA, 20 pmol each of oligonucleotides 4B 
and 19D, 100 p,M of each dNTP, 2 mM MgCI2, 67 mM TrisCl, pH 8.8, 17 
mM (NH4)2504,  6 mM Na2EDTA, 1 mM DTT, 0.02% gelatin, 2 Ixg yeast 
tRNA, 20 U RNasin (Promega Biotec), 33 U reverse transcriptase (AMV 
Super RT; Molecular Genetic Resources, Tampa, FL), and 2.5 U  Taq I 
DNA  Polymerase  (Boehringer-Mannheim  Biochemicals).  The  eDNA 
synthesis reaction was carried out for 60 rain at 42°C followed by 5 min at 
94°C. Subsequent amplification was performed for 30-40 cycles (94°C, 1 
min; 60°C, 2 rain; 72°C, 2 min) with a 7-min incubation at 72°C following 
the last cycle. The products (1.0-1.1 kb) were subcloned into the PCR  TM 
vector using the TA cloning system (Invitrogen, San Diego, CA) and se- 
quenced. 
Ank3 Regulatory Domain (Including PCR6 and PCR7). The regulatory do- 
main of Ank3 was amplified by RT-PCR, using a method designed to am- 
plify large fragments (2), to test for alternatively spliced products, such as 
those characteristic of the Ankl regulatory domain (41, 45). Reverse tran- 
scription was performed in a final volume of 20 Ixl containing: 1.4 p,g total 
RNA, 500 p~M each dNTP, 10 mM DTT, 40 U RNasin, 50 mM TrisCl, pH 
8.3,  75 mM KCI, 3 mM MgCI2,  and 400 U  M-MLV reverse transcrip- 
tase  (GIBCO  BRL).  eDNA synthesis was primed with 1  Ixg oligo-dT 
(d(pT)12.18 (Collaborative Biomedical Products, Lexington, MA) or with 
A3REGR1  (Table I). The mixture was incubated for 120 min at 42°C. 
Amplification of the first-strand cDNA was performed using a mixture of 
KlenTaq I and Pfu DNA polymerases (2). The reaction mixture (50 p,1) 
included: 5 ixl (25%) of the RT reaction mixture, 20 mM TrisC1, pH 8.75, 
I0 mM KC1, I0 mM (NH4)2SO4, 2 mM MgSO4, 0.1% Triton X-100, 100 
p.g/ml BSA, 250 p,M of each dNTP, 125 ng of the appropriate forward and 
reverse primers (A3REGR2 and A3REGF1, Table I), 11.7 U KlenTaq I 
(AB Peptides, St Louis, MO), and 0.078 U Pfu DNA polymerase (Strat- 
agene). The amplification was performed for 30 cycles (94°C, 15 s; 68°C, 
24 rain) with a 7-min incubation at 72°C following the last cycle. PCR6 and 
PCR7 were obtained in this manner and subcloned into the TA vector (In- 
vitrogen) and sequenced. 
cDNA Library Construction and Screening 
Oligo(dT) and random primed kidney eDNA was prepared from C57BL/ 
6J mice using the Timesaver eDNA synthesis kit (Pharmacia, Uppsala, 
Sweden) according to the manufacturer's instructions. Following size se- 
lection (~400 bp) and ligation of NotI/EcoRI adaptors, the cDNAs were 
cloned into the lambda ZAP II vector (Stratagene). The unamplified li- 
braries each contained 460,000  plaques and were 94-98%  recombinant. 
The libraries were initially screened by plaque hybridization (57) of Dur- 
alon UV nylon filters (Stratagene) using PCR1 (described in the previous 
section). Subsequent screenings using PCR2 and an NdeI restriction en- 
zyme fragment of clone pA3-19 (probe 2) were also performed to obtain a 
complete eDNA sequence. Hybridizations and post-hybridization washes 
were performed at 65°C, as described (54). Positive lambda Zap II clones 
were excised in vivo with helper virus according to the manufacturer's di- 
rections, which generated subclones in the Bluescript SK(+ ) plasmid. 
DNA Sequencing 
Plasmid DNA  was  prepared  by  the  cetyltrimethyammonium bromide 
(CTAB) method (3) and sequenced on both strands by the dideoxynucle- 
otide chain termination method, using Sequenase Version 2.0  (United 
States Biochemicals Corp., Cleveland, OH)  according to the manufac- 
turer's directions. 7-Deaza-dGTP was used (Deaza Sequenase Kit; U.S. 
Biochemicals Corp.) and formamide was included in the gels as needed to 
alleviate compressions. Synthetic oligonucleotide primers were used to ex- 
tend all sequences. The data were analyzed using the Genetics Computer 
Group (GCG) programs (21). 
Genetic Mapping 
An MspI restriction fragment length polymorphism (RFLP) was detected 
between the parental strains of an interspecific backcross ([BALB/cJ x 
CAST/Ei]F  a x  BALB/cJ) set. The segregation of this RFLP was followed 
in 77 progeny by Southern blot analysis (57). In addition, to map Ank3 rel- 
ative to SSLP (simple sequence length polymorphism) markers, a Taq I 
RFLP was typed by Southern blot analysis in 94 progeny from an interspe- 
cific backcross involving (C57BL/6J  x  Mus spretus)F  1 females mated to 
M. spretus males (56).  In both cases the hybridization conditions were 
identical to those detailed above. The hybridization probe was the Ank3 
PCR1 product. 
Antibody Preparation 
Regulatory Domain Antibodies. The pGEX-2TK vector (32) was used to 
generate a 45-kD fusion protein containing the NH2-terminal portion of 
glutathione-S-transferase (GST)  and amino acids 1550-1587  and 1784- 
1905 of the regulatory domain of Ank3 (amino acids 1588 to 1783 are al- 
ternatively spliced and were excluded). This segment of Ank3 was chosen 
because it has minimal similarity to Ankl and Ank2, and no significant 
homology to other proteins in the GenEMBL, PIR, and SWISSPROT da- 
tabases. The Ank3 eDNA inserted into pGEX-2TK was generated by the 
polymerase chain reaction (see section entitled PCR3, PCR4, and PCR5 
Peters et al. Characterization of  Ank3  315 above) using the pA3-4 clone (see Fig. 3) as the template DNA. The for- 
ward  primer  (5-CGGGATCCAACCGGATAGACATI'GTAACTC- 
TGCTGG-Y) included a BamHl site (underlined) and the reverse primer 
(5'-GGAATlrCCTCATFTAGGTGCGTCTrCTATGACAAG-Y)  in- 
eluded an  EcoRI  site (underlined) preceded by a  stop codon (double 
underlined). The product was digested, ligated into the vector, and trans- 
formed into E. coli DH5a  using standard techniques (57).  The recom- 
binant protein was expressed and purified as described (32, 55)  and in- 
jected into two rabbits by standard procedures. The  resulting antisera 
were  designated  antiAnk3-R1  (rabbit  No.  11176A)  and  antiAnk3-R2 
(rabbit No. 11176B). Unless noted, antiAnk3-R1 was used. 
Peptide Antibody. A peptide (DKCTWFKIPKVQEVL) corresponding 
to alternatively spliced insert B (see Figs. 3 and 4) at the junction of the re- 
peat and spectrin-binding domains was synthesized by Research Genetics, 
Inc. (Huntsville, AL) and used to generate an antibody (antiAnk3-B) in 
rabbits. 
Affinity Purification of  Ank3-R1 Antiserum 
The Ank3-R1 antiserum was purified by batch adsorption to the GST/ 
Ank3 fusion protein coupled to cyanogen bromide-activated Sepharose 
4B (Pharmacia). The protein was coupled to the beads and washed ac- 
cording to the manufacturer's directions. 5 ml of Ank3-R1 antiserum was 
diluted to 50 ml in 10 mM Tris-HCl (pH 7.5) and mixed gently with 1 ml of 
GST/Ank3 beads at 4°C overnight. The beads were washed (20 vol 10 mM 
TrisCl, pH 7.5, then 20 vol of the same buffer plus 500 mM NaCI), and the 
Ank3-R1 antibodies were eluted with 10 vo1100 mM glycine (pH 2.5). Af- 
ter washing the beads with 10 mM TrisC1 (pH 8.8), Ank3-R1 antibodies 
were further eluted with 10 vol freshly prepared 100 mM triethylamine 
(pH 11.5). After each elution, the antibodies were neutralized with 1 M 
TrisC1  (pH 8.0).  The eluted antibodies were dialyzed overnight at 4°C 
against PBS containing 0.02% sodium azide. 
Preparation of Crude Membranes and Red Blood 
Cell Ghosts 
Mice were anesthetized with avertin and perfused through the left ventri- 
cle with 20 ml cold (4°C) homogenization buffer (0.32 M sucrose, 2 p~g/ml 
leupeptin, 2 ~g/ml aprotinin, 2 mM disodium ethyleneglycol-bis(f~-amino- 
ethyl ether) N,N,N',N'-tetraacetate  (Na~ EGTA),  1 ~g/ml pepstatin A, 
200 p~g/ml  PMSF. Organs were removed and homogenized by hand at 4°C 
using a Dounce homogenizer. Nuclei were removed by centrifugation for 
5 rain at 900 g (4°C), and the crude membrane fraction was collected by 
centrifugation at 30,000 g for 45 rain (4°C).  The pellet was dissolved in 
20% SDS with one-third volume 4×  Laemmli buffer (39)  and boiled 10 
rain prior to electrophoresis and/or storage at -20°C. 
Hemoglobin-depleted ghosts were prepared by repeated lysis in 5 mM 
sodium phosphate (pH 8.0)  containing 1 mM Na2EDTA  and 20 ~g/ml 
PMSF. The final pellet was dissolved in one-third volume 4×  Laemmli 
buffer and boiled 5 min prior to electrophoresis and/or storage at -20°C. 
Immunoblot Analysis 
SDS-PAGE was performed using a 5% stacking/10% running gel (39) and 
prestained molecular weight standards (Bio-Rad Kaleidoscope standards: 
myosin, 202  kD;  [3-galactosidase,  133 kD; BSA, 71  kD; carbonic anhy- 
drase, 41.8 kD; soybean trypsin inhibitor, 30.6 kD; lysozyme, 17.8 kD; and 
aprotinin,  6.9  kD).  Separated proteins were  transferred in  a  Bio-Rad 
Trans Blot SD semi-dry apparatus to Immobilon P membranes (Millipore 
Corp., Bedford, MA) in 48 mM TrisCl, 39 mM glycine, pH 9.2, with 20% 
methanol and 0.035% SDS. A portion of each gel was stained with Coo- 
massie blue prior to transfer to verify the integrity of the proteins. Effi- 
ciency of transfer was monitored by the transfer of the prestained mark- 
ers, by staining the gel after transfer, and by staining a portion of the filter 
with Ponceau S after transfer and prior to blocking, Filters were blocked 
in 5% BSA in TTBS (10 mM TrisC1, 0.05%  Tween-20, 150 mM NaC1, pH 
8.0) for a minimum of 1 h, incubated for 1-2 h with primary antibody (di- 
luted 1:500 in TTBS plus 1% BSA), washed two times in TrBS, incubated 
1 h with goat anti-rabbit IgG alkaline phosphatase conjugate (Bio-Rad) at 
a dilution of 1:3,000 in TTBS with 1% BSA, and washed twice in TI'BS 
and once in TTBS without Tween-20. Unless otherwise indicated, when 
an antibody raised to a GST fusion protein was used, such as antiAnk3-R1 
or -R2, staining was performed in the presence of a 200-fold molar excess 
of purified GST to block any possible reactions with GST-cross-reacting 
epitopes. Bound  antibody was visualized with nitroblue tetrazolium/5- 
bromo-4-chloro-3-indolyl phosphate using a  commercial kit  (Bio-Rad). 
All incubations were performed at room temperature. 
Immunocytochemistry 
Mice were anesthetized with avertin and perfused through the left ventri- 
cle with 20 ml Bouin's fixative. Tissues were excised, placed overnight in 
fresh fixative, and routinely processed to paraffin. For detection of Ank3 
protein, sections were deparaffinized and hydrated in Tris buffer (0.2 M 
TrisC1, pH 7.2), incubated with 1% BSA in the same Tris buffer for 30 min 
at room temperature, washed in 'Iris buffer containing 0.1% BSA, and in- 
cubated overnight in a humidified chamber at 4°C with affinity purified 
antiAnk3-R1 diluted in Tris buffer containing 0.1% BSA. Control slides 
were incubated in buffer alone. The following day, the slides were washed 
in Tris buffer containing "Super Block" (Scytek Laboratories, Logan, UT) 
at a final dilution of 1:30. Bound antiAnk3-R1 was subsequently detected 
using a commercial kit (Kirkegaard and Perry Inc., Gaithersburg, MD) ac- 
cording to the manufacturer's directions. Briefly, the slides were incu- 
bated for 45 min at room temperature with biotinylated anti rabbit IgG, 
washed in Tris buffer, and incubated for 45  min at 37°C  with alkaline 
phosphatase-conjugated streptavidin. Positive reaction was seen as a red 
precipitate. The sections were counterstained with hematoxylin. 
Results 
Isolation of a Novel Ankyrin PCR Product 
Comparison of amino acid sequences of human Ankl and 
Ank2,  and mouse Ankl, with the  evolutionarily distant 
unc44, a C. elegans ankyrin that functions in axonal guid- 
ance, reveals areas of extensive conservation in the distal 
portions  of the  spectrin-binding  domains. For  example, 
the sequence AQWEDITGTT is perfectly conserved in all 
four ankyrins and the sequence CMTDDK(V/E)DKT dif- 
fers at only one amino acid (Fig. 1 a). To identify novel 
ankyrins, degenerative oligonucleotide primers correspond- 
Repeat Domain  Spectrin-  Binding  Regulatory 
Domain  Domain 
1243  A  ~  1302 
Ankl  LRLLCSVIGG  TDQAQWEDIT GTTKLIYANE  CANFTTNVSA RFWLSDCPRT AEAVNFATLL 
Ank-i  LRLLCSVIGG TDQAQWEDIT  GTTKLIYANE CANFTTNVSA PFWLSDCPRT ~-EAVHFATLL 
Ank2  LRLLCSITGG  TTPAQWEDIT GTTPLYFVNE  CVSFTTNVSA RFWLIDCRQI  QESVTFSTQV 
Unc44  LRLLCSITGG  SAPAQWEDIT  GTTQLTFTGD EVSFTTTVSA RFWLMDCQTP  RDAARIGQEV 
•  C  •  B  1352 
Ankl  YKELTAVPYM AKFVIFAK~  DpP~EGRLRCY CMTDDKVDKT  LEQHENFVEW  .......... 
Ank-i  YKELTAVPYM AKFVIFAKMN D;L~EGRLRCY CMTDDKVDKT  LEQHENFVEV  .......... 
Ank2  YREIICVPYM AKFVVFAKSH DPIE~/~LRCF CMTDDKVDKT  LEQQENFAEV  .......... 
Unc44  YNEAISIPYM AKFAVFAI~RT FFVEGQLRVF  CMTDDKEDKT  LEKQEHFKLI  .......... 
b 
Ank-3  AQWEDITGTT  PLTFIKDCV SFTTNVSARFW  LADCHQVLET VGLASQLYR ELICVPYF~ 
FVVFAKTNDP  VESSL}~CFC MTDDRVKDT 
Figure 1.  Cloning of Ank3 eDNA. (a) Comparison of amino acid 
sequences from  a  highly conserved region  within  the  spectrin- 
binding domain of human (Ankl)  and  mouse (Ank-1)  erythro- 
cyte  ankyrin,  human  brain  ankyrin  (Ank2),  and  C.  elegans 
ankyrin (unc44).  The amino acid numbers refer to the sequence 
of Ank3.  The  arrows indicate sequences to  which forward  (A) 
and  reverse  (B)  degenerate  olig0nucleotide  primers  were  de- 
signed for amplification of reverse transcribed mouse cDNA. The 
cDNA synthesis was primed with B  and amplified, by PCR, with 
A  and B  as primers. The resulting products were then screened 
by Southern hybridization using C, another degenerate oligonu- 
cleotide. (b) Sequence of the single, novel 260-bp ankyrin-related 
PCR  product  (Ank-3)  isolated  from  mouse  kidney  using  the 
above strategy. 
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2525531  3  I  21  4  42  I 
11.7 +/- 4.1 
5.2 +I- 2.9 
3.9 +I- 2.5 
6.5 +I- 3.2 
9.1 +I- 3.7 
•  :  CAST/Ei 
=  BALB/cJ 
Figure 2.  Chromosomal localization of Ank3 in the mouse. Ank3 
was mapped using an interspecific ([BALB/cJ ×  CAST/Ei]F1  × 
BALB/cJ) backcross set. The segregation of loci (listed  at left in 
descending order from the centromere) in 77 backcross progeny 
is summarized in the diagram. Open boxes indicate BALB/cJ al- 
leles; filled boxes indicate CAST/Ei alleles. The number of prog- 
eny that inherited each type of chromosome is shown at the bot- 
tom. Map distances between loci (given as percent recombination 
-  SE) are shown at the right.  The fewest recombinations (4/77) 
occurred between Ank3 and the Arnh (anti-Mullerian hormone) 
gene. The data place Ank3 on chromosome 10, 5.2  +-_ 2.9 map 
units proximal to Amh. Additional gene symbols: Zfa, zinc finger 
protein, autosomal; Pah, phenylalanine hydroxylase; Mgf, mast 
cell growth factor; pg, pygmy. 
ing to these sequences were designed (A and B, Table I) 
and  used  in  PCR  amplification  of cDNA  reverse  tran- 
scribed  from  mouse  kidney,  brain,  spleen,  and  thymus 
mRNA.  Ankl  was  recovered  in  abundance  from  the 
spleen and to a lesser extent from brain and thymus. It was 
not  detectable  in  kidney  (data  not  shown).  Ank2  was 
abundant  in brain  and  detectable  in kidney and  thymus, 
but was not recovered from spleen.  In addition,  a 260-bp 
product,  called  PCR1,  was obtained  from kidney,  brain, 
and thymus RNA. It was the predominant ankyrin isoform 
in kidney (data not shown). PCR1 showed 61%  and 76% 
amino acid identity to the corresponding regions of Ankl 
and Ank2, respectively (Fig. 1 b). We designated this ap- 
parent novel ankyrin Ank3 (gene symbol Ank3). 
Ank3 Is Located on Chromosome I0 
To prove  that Ank3 is  encoded by a  gene  distinct  from 
Ankl (mouse Chromosome 8) and Ank2 (mouse Chromo- 
some 3), we genetically mapped Ank3 in the mouse using 
an  interspecific  backcross  ([BALB/cJ  ×  CAST/Ei]FI  × 
BALB/cJ) panel. Analysis of the segregation of an Msp I 
restriction  fragment  length  polymorphism in 77 progeny 
localized Ank3 to Chromosome 10.  The gene  order  and 
map distances (given as percent recombination +_ SE) are 
shown in Fig. 2. Based on the consensus map in the mouse 
(1), Ank3 is ~36 centimorgans (cM) from the centromere. 
From these data, we conclude that the ankyrin gene family 
in the mouse is comprised of at least three distinct genes 
located on three different chromosomes. 
We also mapped Ank3 relative to SSLP markers using a 
(C57BL/6J  ×  Mus spretus)F1  ×  M.  spretus  interspecific 
backcross set (56). The typing data obtained in this panel 
have been deposited in the Mouse Genome Database (ac- 
cession  No.  MGD-CREX-228)  and  can  be  accessed 
through the World Wide Web (http://www.jax.org). No re- 
combinations  occurred  between  Ank3  and  the  marker 
DlOBirlO,  confirming  that  Ank3  is  on  mouse  Chromo- 
some 10. The gene order (from the centromere) and map 
distances (given as %  recombination ___ SE, in order) are: 
DlOBir6  -  8.6  -+  2.9  -  Egr2, DlOMitl5  -  1.1  +  1.1  - 
DlOBirlO, Ank3 -  14.3  --- 3.8 -  DlOMitll. 3 The position 
of the SSLP marker DlOMitl5 is estimated  to be at ~31 
3. Gene names and symbols (1) are: DlOBir6, DNA segment, Chromo- 
some 10, Birkenmeier (Bir)-6; Egr2, Early growth response 2; D10Mit15, 
DNA  segment,  Massachusetts  Institute  of  Technology  (Mit)-15; 
DlOBirlO, DNA segment, Chromosome 10, Bir-10; DlOMit11, DNA seg- 
ment, Chromosome 10, Mit-ll. 
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Figure 3.  Cloning and organization of mouse 
Ank3. (a, CLONES) The organization of rele- 
vant Ank3 cDNA clones obtained by library 
screening (pA3-1, -2, -3, -4, -8, -13, -15, -19, -26, 
and -29) or by the polymerase chain reaction 
(PCR1-7) are shown. Solid lines indicate the por- 
tions  of each  clone/PCR product sequenced 
on  both  strands.  All  cDNA  clones  except 
pA3-1,  pA3-3,  and  pA3-8  were  completely 
sequenced,  cDNA clones pA3-2 and pA3-29 
contain  potential  translation  start  sites  (ar- 
rows). (b, cDNA): The deduced organization 
of Ank3 cDNAs. Alternative splice and start 
sites  are  indicated.  Restriction  enzyme sites 
are  marked  above the  cDNA schematic: A, 
AccI; B, BamHI; C, ClaI; E, EcoRI; H, Hind 
III; K, KpnI; N, NdeI; S, SpeI; X, XhoI. The 
nucleotides at the beginning and end of major 
domains  and the postulated  translation  start 
sites are numbered below the schematic. Hy- 
bridization  probes  described  in  the  text  are 
represented  by  filled  boxes  1-4.  (c,  PRO- 
TEIN)  The  postulated  domain  structure  of 
mouse Ank3 protein. Each domain and alter- 
natively spliced isoform is indicated, with the 
amino acid numbers given above. The 24 repeats of the repeat domain are also shown. Sequences used to generate antibodies to the 
regulatory domain (Ank3-R1) and insert B (Ank3-B) are marked at the bottom. 
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b  ANK3-5KB 
ACTCCTGCTCCCGGGCC  CT  TCTT  TGTTTT  CT  CCCTGGGTTTGTTT  TT  CTTCTACCTGGCT  60 
TGGCTGT  TT  CTTCATTCACTTTT  GAGAAGAGCCCGTC  TCCAAATCGC  CCAGTTACACAAG  120 
TGCCCGGGGCTCTCTGGACTTGTGAGGGT  CCCTGCTACTCTGACTGCCCTGGTATCAAGT  180 
TACTGAAAGTCTACACCCAGGCAGTCCTCATATTTACATACAAATAACTCC  TGGGTTTGC  240 
TTTTATGTCACTATTGGGT  CC  TGCAAGAGGCTT  GCCAGAGCGTCCTTAATCCAATCAGGA  300 
GGCACTTTGAAAGGATGTCTGTTGAGCGGTCAGAAGGATGTTCGTCGCTAT  TAAGTGTT  G  360 
CCACACAAAATTTTTCGCATGTT  TCGGTC  TGAGTTTTTTTTTTTTTT  TT  TTAAAT  CTTCG  420 
GAGTTAAAAAAGT  GAGGAATGATGTACAGCTGCTCAGTTGCCTTCGACAGCTTGGAGAT  G  480 
C  TGAGGGAAACGCTGCAGC  CCTGGT  GAAGAAGATCTGACTAGGGACGGGTTTGGATCCAT  540 
ACCAGGC  TGGTGTGGATTGGGGCTGGTGT  GGACGGCT  TACT  CTAAACCC  CT  GCTTAAGGA  600 
ATT  CCTGGAAGCCTC  GGGAAAGTACTCCCCAACCAGTCGTGGTGGAAATGGCT  TTGCCA  660 
M  A  L  P  5 
ACA gtgaagatgccatcacaggg  .... 
S  e  d  a  i  t  g 
JOINS SPECTRIN DOMAIN 
Figure 4.  Nucleotide sequence,  deduced  amino  acid sequence 
and postulated domain structure of mouse Ank3. (a, Ank3-7kb) 
Amino acids that are identical in human and mouse Ankl, hu- 
man Ank2, mouse  Ank3, and Drosophila ankyrin are shaded. 
The 24  repeats of the repeat domain are underlined and num- 
bered R1-R24. The two small inserts, A and B, at the junction of 
the  repeat and  spectrin-binding domains, and the  alternatively 
spliced acidic sequence (insert C) within the regulatory domain 
are  marked  with  a  double  underline.  The  two  conserved  se- 
quences used to clone Ank3 (by degenerate oligonucleotide RT- 
PCR) are underlined with a single line. (b, Ank3-5kb) The nucle- 
otide sequence of the 5' untranslated region and first six deduced 
amino acids of the ~5-6 kb isoforms of Ank3, which lack the en- 
tire  repeat  domain.  These  sequence  data  are  available from 
EMBL/Genbank/DDBJ under accession numbers L40631  (5-kb 
isoform) and L40632 (7-kb isoform). 
cM  on the consensus map (1). Hence Ank3 is located at 
~32 cM on the consensus map using these markers. The 
data from both backcross sets are therefore in good agree- 
ment. Ank3 is not closely (~1  cM)  linked to  any mouse 
Chromosome 10 mutation. Based upon earlier mouse con- 
sensus maps, we investigated the possibility that an Ank3 
defect could account for the mocha (gene symbol mh) mu- 
tation, a  mouse platelet storage pool deficiency mutation 
located  on  Chromosome  10  (1)  (Peters,  L.  L.,  E.  M. 
Eicher, K. M. John, T. C. Hoock, M. Yialamas, and S. E. 
Lux. 1993. Blood. 82:340a). However, to date, no defect in 
the Ank3 sequence of mocha mice has been found (Peters, 
L.  L.,  K.  M.  John,  and  S.  E.  Lux,  unpublished  observa- 
tions). 
The cDNA Sequence and Predicted Protein Structure 
of Mouse Ank3 
We  used  PCR1  to  screen  two  normal  mouse  (C57BL/ 
6J-+/+)  kidney  cDNA  libraries.  Initially, three  positive 
clones  (pA3-1, pA3-2, pA3-4; Fig. 3)  were  obtained. An 
additional  RT-PCR  product,  PCR2,  was  obtained  from 
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to conserved sequences at the  3'  end of the  repeat do- 
mains of Ankl and Ank2 and reverse primers correspond- 
ing  to  conserved sequences  in  the  spectrin-binding  do- 
mains of Ankl, Ank2, and unc44. Subsequent screenings 
using PCR2 and the 5' NdeI restriction enzyme fragment 
of clone pA3-19 (probe 2, Fig. 3) were performed to ob- 
tain a complete Ank3 cDNA sequence. 
The complete Ank3 cDNA is 7084 nucleotides (Fig. 4 a) 
and encodes a 1,961-amino acid protein with a predicted 
mass  of 214,144 D  and  a  calculated isoelectric point  of 
6.68.  The postulated translation start site is the first in- 
frame methionine and is the only start site that yields a 
structure similar to previous ankyrins. 
Like Ankl and Ank2, Ank3 consists of three domains. 
The 89-kD NH2-terminal "repeat" domain, corresponding 
to amino acids  1-873,  is composed mostly of 24 repeats. 
Each contains 33 amino acids except for repeat 5, which 
has only 29. The Ank3 repeat consensus is: -G-T(P/A)LH- 
AA--G---(V/I)(V/A)--LL---A--(N/D)  .... .  The  Ank3  re~ 
peats  have  the  characteristic  features  that  distinguish 
ankyrin repeats from the similar repeats found in many 
other proteins (10), such as the presence of a hydrophobic 
amino acid in repeat position No. 3 and an N or D in posi- 
tion No. 29 (53). When the ankyrins are aligned and com- 
pared to each other, 19 of the 24 Ank3 repeats are more 
homologous to the corresponding repeat in Ank2 than in 
Ankl.  Overall the  repeat domains  of human  Ank2  and 
mouse Ank3 are 76% identical (Fig. 5). Ank3 also shares 
significant identity to the repeat domain of Ankl (Fig. 5). 
The  entire  domain  is  conserved except for the  first  26 
amino acids. 
When  Ank3  is  compared to Drosophila  ankyrin (24), 
the identity in the repeat domain falls to 56%. The overall 
identity is 51%. Hence, not unexpectedly, Ank3 resembles 
other mammalian ankyrins more than Drosophila ankyrin. 
Despite this, evidence of significant conservation of func- 
tion between fly and mammalian  ankyrins exists.  When 
human  Ankl  and  Ank2,  mouse  Ank3,  and  Drosophila 
ankyrin are compared repeat 1 to repeat 1, repeat 2 to re- 
peat 2, etc., the first 14 repeat positions are all conserved, 
including some positions (e.g., Nos. 1, 3, 8, 11, and 12) that 
vary widely from one repeat to the next, while the "vari- 
able" positions in the last half of the aligned repeats are 
not well conserved. Most likely the amino acids in posi- 
tions Nos. 1, 3, 8, 11, and 12 have critical functions, such as 
protein binding, that vary from repeat to repeat. If so, the 
companion repeats in the various ankyrins must have re- 
tained similar functions throughout evolution. 
Most of the 65-kD spectrin-binding domain (amino acids 
874-1455)  is  also  conserved (Fig.  5),  including  the  basic 
RRRKFH(K/R) sequence (amino acids 1209-1215)  that is 
required for spectrin-binding in Ankl (55). (This basic pep- 
tide is also present in Ank2 and Drosophila ankyrin [24]). 
Some or all of the first 70 amino acids of the Ankl spectrin- 
binding domain are also necessary for full erythroid spec- 
trin-binding  capacity  (18),  but  a  peptide  containing just 
these amino acids does not bind spectrin, at least not when 
it is expressed as a fusion protein (55). Interestingly, the 
first 63 amino acids of the Ank3 spectrin-binding domain 
are reasonably well conserved compared to Ank2 but dif- 
fer completely in Ankl (Fig. 5). This supports the hypothe- 
sis  (55) that this region is responsible for fine tuning the 
preferences of ankyrins for spectrin or fodrin (noneryth- 
roid spectrin). Ank2 preferentially binds fodrin, whereas 
Ankl favors spectrin (15). The spectrin/fodrin preferences 
of Ank3  are  untested,  but judging  from where it is  ex- 
pressed (see below) the protein must interact mostly with 
fodrin. Spectrin binding is thought to be relegated to the 
first half of the spectrin-binding domain since a 32-40 kD 
tryptic peptide  from that  region of Ankl  binds  spectrin 
(55). However, the latter half of the spectrin-binding do- 
main is also well conserved (Fig. 5), suggesting that this re- 
gion as well serves an important, albeit presently unidenti- 
fied, binding or modulating function. 
The  COOH-terminal  "regulatory"  domain  of  Ank3 
(amino acids 1456-1961),  in contrast, is poorly conserved 
(<30% identical, Fig. 5), except for a segment of unknown 
function near the beginning of the domain (amino acids 
1488-1555), which resembles portions of the cytoplasmic 
domain of the tumor necrosis factor alpha receptor, and a 
small  segment  in  insert  C  (see  below).  Comparison  of 
Ankl  and  Ank2  reveals  similar  homologous  and  non- 
homologous regions  (52).  Drosophila  ankyrin shows  no 
significant homology to other ankyrins in the regulatory 
domain (24). 
The  GCG  program  MOTIFS  identifies  76  potential 
phosphorylation sites in Ank3. It is interesting that six of 
these (at residues 822, 830, 838, 844, 848, and 850) are clus- 
tered in  or near insert  A  (see following section)  at  the 
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Figure 5.  Amino acid homology between the 
three ankyrins.  (Top) Schematic of the do- 
main structure of Ank3. The + marks the lo- 
cation of a basic sequence  believed to form 
part of the spectrin  binding site  (55). (Bot- 
tom)  A  comparison  of the  amino  acid  se- 
quences  of mouse Ankl  and  human  Ank2 
with mouse Ank3 reveals extensive homology 
in the repeat domain  and large segments of 
the spectrin-binding domain. Each point rep- 
resents  the  percent  identity  of  10  aligned 
amino  acids. The highest  overall  identity  is 
with human Ank2. Notably, sequence conser- 
vation is lost at the beginning of the spectrin- 
binding domain and also falls dramatically in 
the last two-thirds of the regulatory domain. 
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insert is one of the unique features of Ank3 and probably 
has special binding or regulatory functions. 
The complete nucleotide sequence of the Ank3 cDNAs 
includes  a  number  of alternatively spliced  variants  and 
suggests the use of two different start sites. As described 
later, northern and western blot analyses confirm the ex- 
istence of multiple Ank3 isoforms. 
Ank3 Contains Two Alternatively Spliced Sequences 
between the Repeat and Spectrin-binding  Domains 
The last  13  amino  acids  of clone pA3-19  are  contained 
within the last 17 amino acids of clone pA3-26. Both differ 
from PCR2, where an alternative sequence of 18 amino ac- 
ids is found in the same position (Figs. 3 and 4 a). This sug- 
gests the presence of at least two small inserts at the 3' end 
of the repeat domain of Ank3 where it joins the spectrin- 
binding  domain.  We  designated  the  partial  sequences 
present in cDNA clones pA3-19 and pA3-26 "insert A" 
and the 18-amino acid sequence present in PCR2 "insert 
B", and performed RT-PCR using mouse kidney RNA to 
amplify these and other sequences across the boundary of 
the repeat and spectrin-binding domains. Three new prod- 
ucts, PCR3, PCR4 and PCR5 were obtained (Fig. 3). Nei- 
ther insert A  nor B is present in PCR3. Insert A  alone is 
present in PCR4,  and both inserts are present in PCR5. 
The complete insert A  contains 21 amino acids. We con- 
clude that two inserts are present at the junction of the 
first two domains of Ank3 and that all four possible splice 
variants are transcribed in the kidney. It is noteworthy that 
alternative  splicing  of Ankl  in  the  rat  brain  (40)  and 
mouse cerebellum (9) results in a 24-bp (8 amino acid) in- 
sert at precisely the same location as the A and B inserts of 
Ank3. Although the rat brain and mouse cerebellar inserts 
(TAHISLTG  and  TAMISIMG,  respectively)  resemble 
one another, there is no homology to Ank3 insert A or B. 
The functional role of the various inserts at the junction of 
the repeat and spectrin-binding domains remains to be de- 
fined for both Ankl and Ank3. 
Many Ank3 Transcripts Lack the Repeat Domain 
Ank3 clones pA3-2, pA3-13, and pA3-15 lack the repeat 
domain: a 5'  untranslated region is connected directly to 
the spectrin-binding domain (Fig. 3). To determine if these 
cDNAs are transcribed, we performed northern analyses 
of  mouse  kidney  mRNA  using  domain-specific  probes 
(Fig. 6 a, lanes 1 and 2). Probes to sequences within the 
spectrin-binding  (PCR1)  and  regulatory  (probe  1)  do- 
mains  detect  two  closely migrating  mRNAs  of 7.5  kb 
(faint)  and  6.9  kb  (prominent),  one  mRNA  of 6.3  kb 
(prominent), a broad band at ~5.7 kb (prominent), which 
may be heterogeneous, and minor bands of about 5.1 and 
4.6 kb (Fig. 6 a, lane 2). However, a probe from the Ank3 
repeat domain (probe 2) detects only the 6.9 and 7.5  kb 
mRNAs (Fig. 6 a, lane 1), indicating that the smaller tran- 
scripts and their encoded proteins lack the repeat domain, 
as suggested by the cDNA sequences obtained (Fig. 3). 
Other data support this conclusion and indicate that at 
least two translation start sites are utilized in Ank3.  For 
example, the 5' untranslated regions of the eDNA clones 
that lack a  repeat domain (pA3-2, -15,  and -13)  overlap 
and are distinct from the 5' untranslated region attached 
to the  repeat domain  (clone pA3-29)  (Figs.  3  and 4  b). 
When  mouse  kidney mRNA  is  hybridized  to  a  eDNA 
from the unique 5' untranslated region of the clones lack- 
ing the repeat domain (probe 3,  the EcoRI fragment of 
clone pA3-2, in Fig. 3), the 6.3- and 5.7-kb transcripts are 
strongly labeled, as expected, but at least one 6.9 kb tran- 
script is also marked (Fig. 6 a, lane 3). This large transcript 
must  contain  sequences  that  are  not  present  in  clones 
pA-2, -13, -15 and more distal clones (collectively termed 
"Ank3-5 kb", Fig. 4 b) since the Ank3-5-kb sequence is 
too small. These could be sequences from the repeat do- 
main  or other, presently unknown  sequences.  Similarly, 
two  of  the  transcripts  that  are  assumed  to  represent 
"Ank3-5 kb" are larger (6.3  and 5.7 kb) than the cloned 
fragments  (5.074  kb)  and  must  contain  additional  se- 
quences. 
The only in-frame methionine in this 5' untranslated re- 
gion adds six new amino acids to the spectrin-binding do- 
main. The surrounding nucleotides only match the consen- 
sus sequence of vertebrate translation start  sites  (38)  at 
positions -6 and +4; however, none of the other positions 
is statistically rare. There are stop codons in all frames up- 
stream and the next in-frame methionine is 69-amino acids 
downstream. 
Some Ank3 Molecules Contain an Acidic Insert within 
the Regulatory Domain 
Two major products, PCR6 (1.0 kb) and PCR7 (1.6 kb), 
were obtained by RT-PCR of the Ank3 regulatory domain 
(Fig. 3). PCR7 contains an additional sequence of 588 bp 
(insert C), which appears to correspond to the "2.1 insert" 
of Ankl  (41,  45).  Both inserts  are  located in  the  same 
place in the aligned sequences, both are large (insert C  = 
21.5 kD, 2.1 insert =  17.3 kD), and both are highly acidic 
(pI of insert C  -- 4.0, 2.1 insert =  3.7). However, the se- 
quences  are  quite  different, except for a  short  segment 
(Fig. 5, amino acids 1652-1667), and there is only modest 
conservation of the organization of charged regions and 
predicted  structural  elements.  Judging  from  recovered 
clones (Fig. 3) and from the yield of RT-PCR products, 
most Ank3 RNA transcripts lack insert C. The difference 
was  not  carefully measured  but is  about  threefold. The 
multiple, COOH-terminal,  alternatively spliced products 
of Ankl (27) are not observed in Ank3. 
Northern blot data confirm that insert C is an alterna- 
tively spliced variant that is transcribed in mouse kidney. 
When  kidney  mRNA  is  probed  with  a  sequence  from 
within this exon (probe 4), the 6.9 and 7.5 kb transcripts 
are observed, and the 6.3 kb and minor 5.1 kb bands re- 
main, but the 5.7 and 4.6 kb mRNAs are missing (Fig. 6 a, 
lane 4). 
Ank3 Is the Major Ankyrin in Kidney 
No Ankl or Ank2 is detected in mouse kidney mRNA by 
northern hybridization under conditions where Ank3 gives 
a strong signal (Fig. 6 e). With prolonged exposure faint 
bands of ,~7 kb are barely discernable above background 
in the Ankl and Ank2 lanes (e.g., Fig. 6 e, lane 3). Whether 
these are true signals or cross-hybridization with Ank3 re- 
mains to be determined. 
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and Exist in Many Isoforms 
In addition to kidney, Ank3 was detected in mRNA  from 
skin, brain, lung, testis, intestine, heart, and liver by north- 
ern hybridization (Fig. 6, b-d). It was not detected in nor- 
mal  mouse  spleen  (Fig.  6  c,  lane  2),  in  reticulocytes or 
spleen from mice with a  phenylhydrazine-induced hemo- 
lytic anemia (not shown), in 16 d  fetal liver erythroid pre- 
cursor cells (not shown), or in the cultured lymphocyte cell 
lines JY and Jurkat (not shown). 
In skin, lung, and testis, the overall pattern of Ank3 ex- 
pression is similar to that of the kidney; at least one major 
transcript  at  ~7.0  kb  is  present,  there  is  a  broad  band, 
which potentially encompasses several mRNAs, stretching 
from ~6.3  to  ~5.7  kb,  and some smaller mRNA  species 
(~5.0  kb)  are  evident  (Fig.  6,  b  and  c).  The  ~7.0-kb 
mRNA  predominates  in  cardiac muscle,  but  three  addi- 
tional discrete mRNAs  (6.3, 6.0,  and 5.6 kb) are also ex- 
pressed (Fig. 6 d, lane 4). 
In contrast, in the liver and intestine a 5.5-6.3-kb cluster 
of transcripts make up the major mRNAs (Fig. 6 d); little 
or no expression of the larger spliceoforms is seen. Brain, 
on the  other hand,  contains only large Ank3  transcripts: 
~13,  ~10  and ~7.0  kb  (Fig. 6,  b  and c). The  5.7-6.3-kb 
mRNAs and other small species are not detected. 
Immunoblots Confirm the Existence of Multiple Ank3 
Isoforms in Different Tissues 
The Northern analyses indicate Ank3 is widely distributed 
in mouse tissues and multiple protein isoforms exist. Using 
an  antibody raised in rabbits to  a  GST/Ank3  regulatory 
domain fusion protein (antiAnk3-R1), multiple Ank3 pro- 
tein isoforms  are  detected by Western  blotting of crude 
kidney, brain, liver and testis membranes (Fig. 7 a, lanes I 
Figure 6.  Expression of Ank3  in  mouse  tissues.  (a)  Northern 
blots of kidney Ank3 transcripts using domain-specific  hybridiza- 
tion  probes.  Each  lane  contains  2  ~g  normal  mouse  kidney 
mRNA.  Lines between  lanes indicate corresponding mRNAs. 
The  arrows in  lane 1  indicate two mRNAs of 7.5  and  6.9  kb 
(mRNA  sizes  estimated  relative  to  18S  and  28S  ribosomal 
RNAs). The arrow in lane 2  is at ~6.3 kb. The probes used in 
each lane are as follows. Lane 1: probe 2, repeat domain-specific. 
Lane 2: probe 1, regulatory domain-specific. Lane 3: probe 3, spe- 
cific for the unique 5' untranslated sequence of the Ank3 clones 
that lack the entire repeat domain. Lane 4: probe 4, correspond- 
ing to insert C, the alternatively spliced sequence in the regula- 
tory domain. (b) Expression of Ank3 in normal mouse skin (lane 
1, 2.5  Ixg mRNA) and brain (lane 2, 2.0  Ixg mRNA). The blots 
were hybridized with PCR1, specific to the spectrin-binding do- 
main. Comparative experiments using several tissues reveal that 
PCR1 hybridizes to the same pattern of mRNAs as probe 1 (not 
shown). In the skin, at least one transcript at approximately 6.9 
kb  (arrow) is  present  in  addition to  mRNAs  extending  from 
N6.3-5.7 kb and a smaller 4.7-kb species. In the brain, major tran- 
scripts of ~13 (arrow), ~10, and ~7 kb are present. (c) Expres- 
sion of Ank3 in normal mouse brain (lane 1), spleen (lane 2), lung 
(lane 3), and testis (lane 4). Each lane contains 2 ~g mRNA. The 
arrows are at 13 and 7 kb. The blot was hybridized with a 2.8-kb 
fragment of clone pA3-2 that included all of pA3-2 except the 5' 
sequences corresponding to probe 3. This corresponds to the en- 
tire spectrin-binding domain and most of the regulatory domain. 
(d) Expression of Ank3 in intestine (lane 1, 5 Ixg mRNA), kidney 
(lane 2, 1 ~g mRNA), liver (lane 3, 5 txg mRNA), and heart (lane 
4, 1 ~g mRNA) using PCR1 as the hybridization probe. Arrows 
indicate 7- and 6.3-kb mRNAs. (e) Comparison of Ankl, Ank2, 
and  Ank3  expression in  the  kidney. Each  lane contains 2  ~g 
mouse  kidney  mRNA.  Lane  1  was  probed  with Ank3 probe 
PCR1. Lane 2 was probed with a previously described (55) 4.6-kb 
mouse Ankl cDNA. Both lanes were exposed for 22 h at -80°C 
with two intensifying screens. Lane 3 is a 3-d exposure of lane 2 
and shows a faint band at N6.9 kb. Lane 4 was probed with a 260- 
bp  mouse Ank2 RT-PCR  product,  which  was  amplified from 
mouse brain cDNA with the same primers used to obtain PCR1. 
It was exposed for 22 h at -80°C. The 3-d exposure of lane 4 also 
showed a very faint band at ~7 kb but the dark background pre- 
vented  a  satisfactory photograph.  Note  that  Ankl  and  Ank2 
mRNAs are barely detectable in mouse kidney by northern anal- 
ysis, even with lengthy exposure times. 
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and 200 kD and single bands at 170, 120, and 105 kD are 
observed when blots are probed with the antibody in the 
presence of a 200-fold excess of bacterially expressed GST 
protein. All five bands disappear when the antibody reac- 
tion is performed in the presence of a 200-fold excess of 
the GST/Ank3 fusion protein, indicating they are all Ank3 
specific.  In  addition,  the  antibody  does  not  cross-react 
with Ankl or Ank2. It does not react with Ankl (or other 
proteins) in red cell ghosts (data not shown), and it does 
not detect Ank2 on neuronal cell bodies or dendrites (see 
later section on Immunocytochemistry). 
Multiple Ank3 isoforms are similarly detected in crude 
brain membranes (Fig. 7 a, lane 2), including a predomi- 
nant polypeptide of 215  kD  and  minor isoforms of 180, 
160,  145,  135,  120,  and  105 kD.  In testis  and liver crude 
membranes,  small  amounts of the  120-  and  105-kD  iso- 
forms are found (Fig. 7 b, lanes 3 and 4). The 105-kD iso- 
form is the major species observed in crude platelet mem- 
branes (not shown). 
The B Insert is Contained in a Single 170 kD Isoform 
When antibody raised to a peptide sequence within the al- 
ternatively spliced B  insert  (antiAnk3-B)  is  used  as  the 
probe, a  170-kD isoform is present in crude membranes 
from kidney, liver, and testis but not brain (Fig. 7 b). It is 
also observed in platelet membranes (not shown). In the 
kidney it co-migrates with the  170-kD  peptide  detected 
with the Ank3 regulatory domain-specific antibody (anti- 
Ank3-R1). This antiserum does not detect the 170-kD iso- 
form in testis and liver (Fig. 7 b), but a companion antise- 
rum  (antiAnk3-R2),  raised  against  the  same  GST/Ank3 
regulatory domain fusion protein, does (not shown). We 
conclude that the B insert is expressed in a single isoform 
of 170 kD, and that it is present in kidney, testis, liver, and 
platelet membranes, but not in membranes prepared from 
brain. 
Immunocytochemistry 
We performed immunocytochemical staining of a variety 
of mouse tissues using affinity purified antiAnk3-R1, pre- 
pared  against  the  GST/Ank3  regulatory  domain  fusion 
protein. In general, Ank3 is present in epithelial tissues, 
muscles, and axons (Figs. 8 to 10). 
Epithelial Tissues 
Skin. Intense staining is seen in the epithelium of the skin 
(Fig. 8, a and c), including that lining the sweat glands and 
hair follicles (Fig. 8 a, arrow). 
Lung. Intense staining is also seen in the epithelium of 
the lung airways, where an apical-lateral concentration of 
reaction product is apparent (arrows)  in addition to signif- 
icant cytoplasmic staining (Fig. 8 d). The walls of the lung 
respiratory passages  (alveoli)  are  negative.  A  subset  of 
lung interstitial  cells is  clearly positive  (Fig.  8 f, arrow). 
The identity of these  cells is  uncertain.  The most likely 
possibility is lung macrophages, since the cells resemble 
macrophages and both peritoneal and bone marrow mac- 
rophages contain Ank3 (Hoock, T. C., L. L. Peters, and 
S. E. Lux. 1994. Mol. Biol. Cell. 5[Suppl]:45a.) 
Figure 7.  Western  blots of membranes  from various mouse tis- 
sues. (a) Crude membranes from normal mouse kidney (lane 1), 
brain  (lane  2),  testis  (lane  3),  and liver  (lane  4)  probed with 
antiAnk3-R1,  an antibody  raised  to a glutathione-S-transferase 
(GST/Ank3  fusion protein). When probed with the same  anti- 
body in the presence of a 200-fold molar excess of purified GST/ 
Ank3  fusion protein, the immunoreactive  species indicated  by 
the arrows  were no longer  detected, indicating  that these  are 
Ank3 specific isoforms. In kidney, five isoforms are present:  a 
doublet of 215/200 kD (top arrow, lane 1) and three smaller iso- 
forms of 170, 120, and 105 kD. In the brain, the 215-kD isoform 
predominates. Smaller amounts of 180-, 160-, 145-, 135-, 120- and 
105-kD species are also detected.  In testis, the major isoform is 
120 kD. Small amounts of the 105-kD isoform are also observed. 
In liver, the 120- and 105-kD isoforms are present at barely de- 
tectable levels. The prominent band at 70 kD is nonspecific (NS) 
as it is seen even in the presence of excess GST/Ank3 fusion pro- 
tein.  (b)  Crude  normal mouse membranes  from testis (lane 1), 
liver (lane 2), kidney  (lane 3), and brain  (lane 4) probed with 
antiAnk3-B, a peptide antibody directed against the B insert. A 
170-kD isoform (arrow) is present in all but the brain membranes 
and is not detected when pre-immune serum is used in place of 
the antibody. 
Intestine. A  diffuse (cytoplasmic) Ank3 staining pattern 
is seen in the intestinal absorptive epithelium (Fig. 8, g and 
i). Interestingly, there is significantly less intense staining 
of epithelial cells in the crypts as compared to the villi (Fig. 
8 g), which suggests that Ank3 is a marker of intestinal ep- 
ithelial differentiation and maturation. In addition, the in- 
testinal smooth muscle is positive for Ank3, as are nerve 
ganglia (Fig. 8 g, arrow). In contrast, the connective tissue 
elements in the lamina propria do not stain. 
Pancreas. In the pancreas, apical staining of acinar cells 
(arrow, Fig. 9 c) and intense staining of the epithelial lin- 
ing of the ducts (arrow) is apparent. 
Liver. Ank3 immunoreactivity is weak in the liver; only a 
faint diffuse staining pattern is observed (not shown). 
Kidney. Intense  Ank3  immunoreactivity is  seen in  the 
kidney (Fig. 10, d-i). In the cortex, the macula densa (Fig. 
10 d, left arrow), distal convoluted tubule, and cortical col- 
lecting ducts (Fig. 10 d, right arrow) are strongly positive, 
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convoluted tubules (P, Fig. 10 d) are less reactive and the 
stain is more diffusely distributed, perhaps due to the ex- 
tensive membrane interdigitations that characterize these 
cells. The glomeruli (G, Fig. 10 d) do not stain. In the me- 
dulla, the descending and ascending thin limbs of the loop 
of Henle are negative, while the thick ascending limb is 
positive (Fig. 10 g, lower arrow). The outer medullary col- 
lecting ducts  also  stain  intensely (Fig.  10,  e  and f), but 
Ank3  immunoreactivity  falls  dramatically  in  the  inner 
medullary collecting ducts  (Fig.  10,  g  and  h).  A  strong 
basal-lateral  concentration  of immunoreactivity can  be 
seen in the thick ascending limbs and outer medullary col- 
lecting ducts (Fig. 10, e and g). The epithelium of the renal 
papilla and ureter is also strongly positive (not shown). 
Muscle 
Cardiac muscle (Fig. 9 e), skeletal muscle underlying the 
skin (Fig. 9 f), and smooth muscle in the intestine (Fig. 8 g) 
are  all Ank3  immunoreactive. In the  heart, the interca- 
lated discs (arrows, Fig. 9 e) are clearly positive. Skeletal 
muscle shows a striated pattern that is consistent with lo- 
calization at the transverse tubular membrane (26, 42). 
Neural Tissues 
In neural tissue, the axons of outer granular and pyramidal 
layers of the  cerebral cortex and the  hippocampus  (not 
shown) are positive, particularly the initial segments (Fig. 
10 a, arrow). Although it is difficult to discern at this mag- 
nification, the cell bodies and dendrites appear negative. 
lank2  is  located  in  neuronal  cell bodies  and  dendrites 
(35)]. The axons of cerebellar Purkinje cells are also posi- 
tive (Fig. 10 b, arrow) and Purkinje cell bodies and den- 
drites are negative.  It is noteworthy that in sections of 
the  cerebellum stained  with  high  concentrations of the 
Ank3 antiserum (1:25-1:50 dilution of antiAnk3-R1 vs the 
1:100-1:250 dilution used in all other experiments), diffuse 
staining of the molecular layer of the cerebellum occurred, 
which resulted in visible outlining of the unstained Purkinje 
cell dendritic  trees  (not  shown).  Hence, it is  clear that 
Purkinje cell dendrites do not contain Ank3 protein. How- 
ever, it is difficult to be certain unmyelinated axons of the 
molecular layer of the cerebellum are really Ank3 posi- 
tive, because  of the  high  concentration  of antibody re- 
quired  to  stain  this  area.  As  noted  earlier,  peripheral 
nerves (Fig. 8 g, arrow) also stain for Ank3. 
Other Tissues 
Leydig Cells. In the testis,  discrete areas within the cyto- 
plasm of the interstitial (Leydig) cells are intensely posi- 
tive (Fig. 9 a, middle and right arrows), while the Sertoli 
cells and  seminiferous tubules  stain  very weakly or not 
at all. 
Megakaryocytes.  Although  the  majority of the  cells  in 
the spleen do not contain immunoreactive Ank3, particu- 
larly lymphocytes and reticuloendothelial cells, megakary- 
ocytes are diffusely stained (Fig. 9 h, arrows). 
Discussion 
Ank3 Is the Major Ankyrin in the Kidney and Other 
Epithelia and Is Probably Involved in the Targeting/ 
Maintenance of NalK-ATPase and Other Proteins in 
Plasma Membranes 
Recent  evidence  shows  that  many  integral  membrane 
transporters and adhesive proteins bind ankyrins. The un- 
doubtedly incomplete list already includes the a subunit of 
Na/K-ATPase in renal tubules (20, 50), intestinal epithe- 
lium (22), retinal pigment epithelium (30), choroid plexus 
(47), and brain (58); the voltage-dependent Na channel in 
neurons (61) and at the neuromuscular junction (25); the 
amiloride-sensitive Na channel in the kidney (60); the Na/ 
Ca exchanger in the heart (42); the H/K-ATPase in gastric 
parietal  cells  (59); the  hyaluronic acid  receptor (CD44) 
(43) and inositol 1,4,5-triphosphate (IP3) receptor (11) in 
lymphocytes; a group of neurofascin/Ll-like putative cell 
adhesion molecules in the brain (17); and, of course, the 
Cl/HCO3-anion exchanger (AE1, band 3) in erythrocytes 
(7). Ankyrins also bind a related anion exchanger (AE3) 
in the brain (48), and probably bind a shortened isoform of 
AE1 in the intercalated cells of the renal collecting duct 
(23). In all well studied cases, the integral membrane pro- 
teins bind to part of the ankyrin repeat domain and are in 
turn linked to the spectrin/fodrin-based membrane skele- 
ton. These interactions appear to play a role in establish- 
ing  and/or  maintaining  a  polarized  distribution  of  the 
ligands in the membranes of non-erythroid cells (22, 23, 
25, 30, 31, 47, 49, 50, 60, 61). 
Ankl  and  Ank2  bind  to  many of the  proteins  listed 
above in in vitro binding assays, but are unlikely to do so 
in  vivo because  they are  expressed in  different tissues. 
Ankl is found in erythroid cells (53, 54), myocytes (9), en- 
Figure 8. Immunocytochemical detection of Ank3 in mouse skin, lung, and intestine. In this and subsequent figures, red reaction prod- 
uct indicates the presence of Ank3 protein. The primary antibody is affinity purified antiAnk3-R1. Sections incubated in the absence of 
primary antibody serve as controls. All sections are counterstained  with hematoxylin. (a) Skin. A positive reaction is seen in epithelial 
cells (arrow), including the epithelial cells lining the hair follicles, sebaceous glands and sweat glands. (b) Skin control. (c) High magnifi- 
cation of the skin showing intense Ank3 staining in all but the outermost, cornified layers of the epithelium. (d) Lung. Intense Ank3 re- 
action product is present in the epithelial cells of the conducting airways, where an apical-lateral  concentration is observed (arrows). 
Positive staining is also seen in the smooth muscle layers (right). (e) Lung control. (f) High magnification of the lung showing an Ank3 
immunoreactive  interstitial  cell (arrow), probably a macrophage,  next to, but not abutting, alveolar airspaces. (g) Intestine.  Diffuse 
Ank3 staining is present in the absorptive epithelia (E) of the intestinal villi. Within the intestinal crypts (C), less intense staining is seen. 
The smooth muscle (SM) of the muscularis layer is positive, and a nerve plexus between the muscle layers is intensely positive (arrow- 
head). (h) Intestine control. (i) High magnification of a portion of an intestinal villus showing the diffusely stained absorptive epithelium 
(E). Connective tissue components of the lamina propria (Lp) are negative. Bar, 10 ixm. 
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and spinal cord neurons (9, 35, 54), and possibly hepato- 
cytes (52). Ank2 is limited to neurons and glia (12, 35, 52, 
54). In adult animals both ankyrins are localized to neu- 
ronal cell bodies and dendrites. Fetal mice and rats express 
a giant isoform of Ank2 that is found in unmyelinated ax- 
ons, but this protein disappears within a few days of birth. 
They also express an isoform of Ank2 in fetal liver precur- 
sors (53). 
Numerous  studies have identified "ankyrins" in  other 
tissues using antibodies raised to Ankl or Ank2 (4, 5, 14, 
15, 22, 23, 25, 26, 29, 34, 42, 60). However, in all cases the 
antibody was raised to whole Ankl or Ank2 (8, 15) or to 
their conserved portions (the repeat and spectrin binding 
domains) (6), and presumably lacked specificity. In many 
of these studies the problem of specificity was accentuated 
by using an antiserum raised to an ankyrin of one species 
to probe tissues of another species, by immunizing with 
SDS-denatured proteins, or by using affinity chromatogra- 
phy to concentrate cross-reacting antibodies. For example, 
in one case (14) an antibody to pig brain ankyrin (Ank2) 
was affinity purified on a column containing bovine brain 
ankyrin, producing a reagent that reacted with all cells of 
the rat kidney. More recent surveys of ankyrin expression, 
using specific antibodies to Ankl  (52) or Ank2 (36, 52), 
show a much more restricted distribution, consistent with 
the expression of Ankl  and Ank2 detected by northern 
blotting (9, 52, 54). In particular the kidney does not react 
significantly with such sera (52). 
These studies indicate that additional ankyrins must ex- 
ist in cells or sites that lack Ankl or Ank2 but contain im- 
munoreactive molecules. Ank3 is one such ankyrin. It is 
the major and possibly the only ankyrin in the kidney and 
other epithelial tissues, the major axonal ankyrin in adult 
neurons, and probably the major ankyrin in muscle. It is 
also found in some specialized cells, including megakaryo- 
cytes, macrophages, and the interstitial (Leydig) cells of 
the testis. 
In the kidney the distribution of Ank3 (Fig. 10) corre- 
lates very closely with the activity of Na/K-ATPase in vari- 
ous segments of the nephron (33). Both proteins are ex- 
pressed  in  the  proximal  convoluted  tubule,  the  thick 
ascending limb of the loop of Henle, the distal convoluted 
tubule, and the collecting duct, and neither protein is de- 
tectable in the thin limbs of the loop of Henle (Fig. 10) 
(Piepenhagen,  P.A.,  and  W.J.  Nelson.  1994.  Mol.  Biol. 
Cell.  5(Suppl.):367a).  Na/K-ATPase  is  localized  to  the 
basal-lateral surfaces of the epithelial cells in these seg- 
ments and, where its location can be discerned, Ank3 also 
has a basal-lateral distribution. Given these facts, and the 
fact that Na/K-ATPase can be isolated from kidney com- 
plexed with an ankyrin and fodrin (49-51), it is very likely 
that Ank3 is involved in the targeting/maintenance of Na/ 
K-ATPase within plasma membrane domains in epithelial 
cells," and perhaps in other cells. Based on location, other 
ankyrin-binding molecules that may serve as ligands for 
Ank3  include  the  amiloride-sensitive  and  voltage-gated 
Na-channels, the H/K-ATPase, the Na/Ca exchanger, C1/ 
HCO3  exchangers, and  members  of the  neurofascin/L1- 
like family of cell adhesion molecules. 
Some Forms of Ank3 Lack the Repeat Domain 
Ank3 exists in diverse forms. In the kidney the transcripts 
can be subdivided into four groups: two relatively discrete 
RNAs of ~7.5- and 6.9-kb, at least one RNA at 6.3  kb, 
a broad band of about 5.7 kb, and minor bands of 5.1 and 
4.6 kb. 
The 6.9- and 7.5-kb species ("Ank3-7kb") are the only 
ones that are labeled by probes to all three domains, in- 
cluding the repeat domain (Fig. 6 a, lane 1). Several obser- 
vations  suggest  these  two  transcripts  encode full length 
kidney Ank3 with or without insert C (an acidic sequence, 
located in the regulatory domain that is analogous to the 
"2.1  insert" of Ankl  [45]).  PCR products that  differ by 
~0.6 kb, the size of insert C, are observed when the entire 
coding  sequence  of  Ank3-7kb  is  amplified  (data  not 
shown) and two proteins (215 and 200 kD) close to the ex- 
pected sizes (214 and 193 kD) are detected on immuno- 
blots (Fig. 7 a, lane 1). However the situation seems to be 
more  complicated  since  the  6.9-  and  7.5-kb  transcripts 
both hybridize to a probe from insert C (Fig. 6 a, lane 4). 
Further investigations are required. 
In contrast, the 6.3-  and 5.7-kb RNAs lack the repeat 
domain and are tentatively classified as variants of "Ank3- 
5kb". They fail to hybridize to probes from the repeat do- 
main and they all contain the unique 5'  untranslated re- 
gion found in cDNA clones in which the repeat domain is 
missing (Fig. 6 a, lane 3). They appear to encode a protein 
containing just  the  spectrin-binding  and  regulatory do- 
mains, with (6.3 kb) or without (5.7 kb) insert C. PCR sur- 
veys reveal the expected products and,  as anticipated, a 
probe from insert C fails to hybridize to the 5.7-kb band 
(Fig. 6 a, lane 4). More importantly, two proteins (120 and 
105 kD) very close to the predicted sizes (121 and 100 kD) 
are easily detected in crude renal membranes, and in fact 
are the major protein species (Fig. 7 a, lane 1). This strongly 
suggests that the truncated Ank3-5kb protein is actually 
synthesized, although additional evidence is needed to for- 
mally prove this point. Unfortunately, attempts to prepare 
an antibody specific to the six unshared NH2-terminal amino 
acids of Ank3-5kb, or to isolate and sequence the NH2-ter- 
minal ends of the 120- and 105-kD proteins have so far been 
unsuccessful. 
Figure 9.  Immunocytochemical detection of Ank3 in mouse testis, pancreas, muscle, and spleen. (a) Testis. Large cytoplasmic inclusions 
containing abundant Ank3 are present within the testosterone-secreting  interstitial cells of Leydig (middle and right arrows). Weak, dif- 
fuse Ank3 reactivity is seen in the rest of the cytoplasm. A portion of a seminiferous tubule is seen on the left. These stain very weakly 
or not at all. No Ank3 staining is seen in the endothelial lining of small blood vessels (top left arrow). (b) Testis control. (c) Pancreas. 
Acinar cells show apical staining for Ank3 (lower arrow). Epithelial cells lining the ducts are strongly positive (upper arrow). (d) Pan- 
creas control. (e) Heart. Ank3 is present throughout cardiac muscle fibers and is concentrated at intercalated discs (arrows). (f) Skeletal 
muscle. Skeletal muscle of the skin is Ank3 immunoreactive, while the surrounding connective tissue is negative. (g) Skeletal muscle 
control. (h) Spleen. Megakaryocytes (arrows) show diffuse Ank3 staining. (i) Spleen control. Bar, 10 ixm. 
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positive for Ank3. (b) Cerebellum. The molecular layer (M) is shown at top and the granule cell layer (G) is at the bottom. The unmy- 
elinated neurons of the molecular layer appear negative while the axons of the Purkinje cells (arrow) are positive. (c) Brain (cerebral 
cortex) control. (d) Kidney cortex. Intense, basal-lateral Ank3 staining is seen in the macula densa (left arrow), distal convoluted tu- 
bules, and cortical collecting ducts (right arrow). Proximal convoluted tubules (P) show weaker and more diffuse Ank3 staining. A 
glomerulus (G) is negative. (e and JO Outer medullary collecting ducts show strong basal-lateral  concentration of Ank3. (g) The junction 
of the outer and inner medulla. The epithelial cells of a thick ascending limb (lower arrow) and an outer medullary collecting duct (up- 
per arrow) stain intensely for Ank3, while the inner medullary collecting ducts, at the bottom, are weakly stained. (h) High magnifica- 
tion photograph showing the abrupt transition (arrow) from heavy to light Ank3 staining of collecting ducts at the junction of the outer 
and inner medulla. (i) Kidney control. Bar, 10 ixm. The minor 5.1- and 4.6-kb mRNAs  also lack the repeat 
domain and seem to differ by the presence or absence of 
insert C (Fig. 6 a, lane 4); however, it is not clear whether 
they are translated into stable proteins. 
The fifth Ank3 protein in kidney, the 170-kD isoform, is 
more mysterious. This is the only Ank3 species that con- 
tains  the  B  insert.  Since  it  is  detected  by  antiAnk3-R1, 
which was  made  to a  unique sequence  near the  COOH 
terminus of the regulatory domain, it must also contain se- 
quences from that region. It is not clear what other parts of 
Ank3 are present in this isoform.  The size of the related 
mRNA transcript is also unknown. However, it should be 
possible  to use an antibody to the B  insert to see  which 
cells  in the kidney express  this protein and perhaps dis- 
cover its ligands. 
The Truncated Ank3-5kb Protein May be Associated 
with Cytoplasmic Structures 
It is notable  that the 6.3/5.7 kb  Ank3  RNAs  and/or the 
presumptively  related  120/105-kD  proteins  are  the  only 
forms  of  Ank3  detectable  in  intestine,  testis,  and  liver 
(Figs.  6  and 7). In these tissues immunoreactivity is con- 
centrated in the cytoplasm and is not evidently associated 
with the membrane (e.g., see Fig. 8, h and i). In contrast, in 
tissues containing the ~7-kb  forms of Ank3, such as kid- 
ney, lung, heart and brain (Figs.  6  and 7), plasma  mem- 
brane staining is observed, often in a polarized distribution 
(e.g., Fig. 8 d or Fig. 10, e and f). The observations suggest 
that the repeat domain is required to attach Ank3 to its in- 
tegral membrane ligands and, in its absence, that the pro- 
tein remains in the cytoplasm or attaches  to cytoplasmic 
structures.  Preliminary  studies  of  Ank3  in  mouse  bone 
marrow  macrophages  support  this  concept.  The  macro- 
phages only have ~5.0- and ~3.6-kb Ank3 transcripts, nei- 
ther of which contains the repeat domain. The related pro- 
teins  (120  and  105  kD)  are  associated  solely  with  the 
membrane of phase dense, late lysosomal vesicles, and not 
with the plasma  membrane  (Hoock,  T.  C.,  L.  L.  Peters, 
and S. E. Lux. 1994. Mol. Biol. Cell. 5[Suppl]:45a). These 
preliminary observations suggest that ankyrins lacking the 
repeat domain may play a role in intracellular vesicle sta- 
bilization, sorting or targeting, or have other still undiscov- 
ered functions. 
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